The Precision Peptide Genetic Test reveals predispositions in key GLP-1 and GIPR pathways, which can inform how your body may respond to semaglutide therapy
It is particularly useful for studying receptor desensitization, sustained signaling pathway activation, and for comparative studies with other GLP-1 receptor agonists
Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies
Sipping water throughout the day rather than consuming large amounts at once may be more comfortable
Our program utilizes compounded medication, which contains the same active ingredient but is prepared by a licensed pharmacy, making it significantly more affordable and accessible
Less than 1% of oral semaglutide makes it into your bloodstream, compared to around 89% of injectable semaglutide